Asthma, Covid19
Conditions
Keywords
asthma, asthma control, COVID19
Brief summary
This research project aims to investigate the impact of COVID-19 on asthmatic patients, particularly focusing on whether the viral infection exacerbates asthma or affects control and lung function in the short to medium term. The study plans to collect and compare data from two groups of asthmatic individuals - those who have experienced a SARS-CoV-2 infection requiring emergency consultation or hospitalization and a matched control group without such infection. Both groups will be followed for one year, with lung function tests conducted at six months and monitoring of exacerbations and changes in Asthma Control Test (ACT) throughout the year. The objective is to enhance understanding of how COVID-19 affects asthmatic patients, leading to improved recommendations, preventive measures, and treatment adjustments based on the study's findings.
Detailed description
The COVID19 pandemic is having an immeasurable impact on the economy and on morbidity and mortality. Knowledge and scientific evidence about this disease is advancing rapidly, but it is not yet known whether asthmatic patients suffering from COVID19 have an exacerbation of asthma, or whether this viral infection has an impact on control and lung function in the short to medium term. The aim of this study is to define the changes that occur in these two parameters in asthmatic patients suffering from COVID19. To this end, asthmatic patients who have suffered a SARS-CoV-2 infection and who have required an emergency consultation or hospitalisation will be collected in a pneumology consultation and matched by age, sex and severity of asthma with a group that has not suffered the same. Both will be followed for one year, and lung function will be tested at six months and exacerbations and changes in ACT during the following year. These data are intended to improve the available knowledge on the impact of IDVC19 on asthma patients with a view to making appropriate recommendations, prevention and treatment adjustments in line with the results obtained.
Interventions
DIAGNOSTIC_TESTspirometry
Lung function test: pre and post bronchodilator spirometry
OTHERAsthma control test
Asthma control test
Sponsors
Sociedad Española de Neumología y Cirugía Torácica
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
12 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* 12 -80 years * Asthma diagnosis according to guidelines * Follow up on asthma clinics in one of the participant hospitals
Exclusion criteria
* Other severe respiratory condition independent of asthma
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Asthma control | 6 months | Change in score of Asthma Control Test (ACT). Min 5 máx 25 (the higher score indicates better control) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Asthma function | 6 months | Change in FEV1 (Forced expiratory volume in one second) |
Countries
Spain
Outcome results
None listed